There is evidence that implicates ELOVL5 (61), DHCR7 (71), ACOT7 (72), ME1 (73), ACACB (74), FASN (75), ACSL6 (76), CPT1B (77), FAAH (78), ANGPTL4 (79), STARD3 (80), SRD5A1 (81), HSD171B (82), NCOA1 (83), UGT8 (40), INPP4B (84), DGAT2 (85), MBOAT1 (86), PTGR1 (87), and PLD6 (88) in breast cancer prognosis. This evidence concerns the gene ELOVL5 and breast cancer.